Cognition Therapeutics (CGTX) Revenue & Revenue Breakdown
Cognition Therapeutics Revenue Highlights
00
Cognition Therapeutics Revenue by Period
Cognition Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Cognition Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Cognition Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $250.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $372.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Cognition Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Cognition Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AGEN | Agenus | $103.46M | $30.23M |
| SPRO | Spero Therapeutics | $47.98M | $11.80M |
| SEER | Seer | $14.17M | $4.12M |
| IRD | Opus Genetics | $10.99M | - |
| SRZN | Surrozen | $10.65M | $983.00K |
| VTGN | VistaGen Therapeutics | $1.06M | $244.00K |
| MCRB | Seres Therapeutics | - | $351.00K |
| CGTX | Cognition Therapeutics | - | - |
| GLSI | Greenwich LifeSciences | - | - |
| ATOS | Atossa Therapeutics | - | - |
| TVGN | Tevogen Bio | - | - |